World Council for Health Supports the Call for Immediate Removal of mRNA Products

World Council for Health stands in solidarity with the concerns raised in this open letter to Secretary Kennedy and FDA Commissioner Dr Makary. We support the call for the immediate removal of all mRNA-based products from the market, in line with overwhelming evidence* of harm documented in peer-reviewed research and the government’s own data, the harms of which WCH has been reporting on since 2021 when we called for a halt to the Covid-19 mRNA injections.

It is deeply concerning that the recently released MAHA Report, which aims to address the most pressing health threats facing Americans, fails to acknowledge the issue hiding in plain sight – the extensive and well-documented harms associated with mRNA technology.

We urge Secretary Kennedy and all relevant authorities to take immediate, decisive action to protect public health by removing these products from the market.


*References

Expert Hearing: Covid Vaccines—Where do we stand in 2024?

https://rumble.com/v53d6zl-expert-hearing-covid-vaccineswhere-do-we-stand-in-2024.html?e9s=src_v1_ucp

The Novelty of mRNA Viral Vaccines and Potential Harms: A Scoping Review

https://www.mdpi.com/2571-8800/6/2/17

mRNA Harms: A WCH Health Science Committee Special Report

https://rumble.com/v2lnxqw-mrna-harms-a-wch-health-science-committee-special-report.html

Pharmacovigilance Report

https://www.worldcouncilforhealth.org/covid-19-vaccine-pharmacovigilance-report/

*Studies

Sequencing of bivalent Moderna and Pfizer mRNA vaccines reveals nanogram to microgram quantities of expression vector dsDNA per dose,
Kevin McKernan, Yvonne Helbert, Liam T. Kane, and Stephen McLaughlin, Researchgate preprint, April 2023, DOI:10.31219/osf.io/b9t7m
https://osf.io/preprints/osf/b9t7m_v1

DNA fragments detected in monovalent and bivalent Pfizer/BioNTech and Moderna modRNA COVID-19 vaccines from Ontario, Canada: Exploratory dose response relationship with serious adverse events.
David J. Speicher1, Jessica Rose2, L. Maria Gutschi3, David Wiseman4, Kevin McKernan5 Researchgate preprint, October 2023, DOI:10.31219/osf.io/mjc97.

https://www.researchgate.net/publication/375065939_DNA_fragments_detected_in_monovalent_and_bivalent_PfizerBioNTech_and_Moderna_modRNA_COVID-19_vaccines_from_Ontario_Canada_Exploratory_dose_response_relationship_with_serious_adverse_events

Dr Phillip Buckhaults’ testimony:

https://www.scstatehouse.gov/CommitteeInfo/SenateMedicalAffairsCommittee/PandemicPreparedness/Phillip-Buckhaults-SC-Senate-09122023-final.pdf

HIV MAN-MANIPULATED CORONAVIRUS GENOME EVOLUTION TRENDS,
Jean claude Perez1, Luc Montagnier2, International Journal of Research, ISSN (Print): 2394-3629 July 2020, Vol 8(07), 217 – 263 DOI: https://doi.org/10.29121/granthaalayah.v8.i7.2020.678, Vol 8(07), 217 – 263(Vol 8(07), 217 – 263), Vol 8(07), 217 – 263, 2020.
https://zenodo.org/records/3975589

Expanded Spectrum and Increased Incidence of Adverse Events Linked to COVID-19 Genetic Vaccines: New Concepts on Prophylactic Immuno-Gene Therapy, Iatrogenic Orphan Disease, and Platform-Inherent Challenges,
Janos Szebeni 1,2,3 Pharmaceutics. 2025 Mar 31;17(4):450. doi: 10.3390/pharmaceutics17040450,
https://pmc.ncbi.nlm.nih.gov/articles/PMC12029998

Circulating Spike Protein Detected in Post– COVID-19 mRNA Vaccine Myocarditis,
Lael M. Yonker , MD*; Zoe Swank, PhD*; Yannic C. Bartsch, PhD*; Madeleine D. Burns , MS; Abigail Kane Brittany P. Boribong, PhD; Jameson P. Davis, BS; Maggie Loiselle, BS; Tanya Novak , PhD; Yasmeen Senussi Chi-An Cheng , PhD; Eleanor Burgess, MS; Andrea G. Edlow, MD; Janet Chou, MD; Audrey Dionne , MD; Duraisamy Balaguru , MD; Manuella Lahoud-Rahme , MD; Moshe Arditi , MD; Boris Julg, MD, PhD; Adrienne G. Randolph , MD; Galit Alter, PhD; Alessio Fasano , MD†; David R. Walt , PhD†, Circulation. 2023 Jan 4;147(11):867–876. doi: 10.1161/CIRCULATIONAHA.122.061025
https://pmc.ncbi.nlm.nih.gov/articles/PMC10010667

COVID-19 mRNA Vaccines: Lessons Learned from the Registrational Trials and Global Vaccination Campaign, M. Nathaniel Mead 1 , Stephanie Seneff 2 , Russ Wolfinger 3 , Jessica Rose 4 , Kris Denhaerynck 5 , Steve Kirsch 6 , Peter A. McCullough 7, 8 , Cureus. 2024 Jan 24;16(1):e52876. doi: 10.7759/cureus.52876
https://pmc.ncbi.nlm.nih.gov/articles/PMC10810638

‘Spikeopathy’: COVID-19 Spike Protein Is Pathogenic, from Both Virus and Vaccine mRNA
Peter I. Parry 1,2,*, Astrid Lefringhausen 3, Conny Turni 4, Christopher J. Neil5, Robyn Cosford 3, Nicholas J. Hudson 6 and Julian Gillespie 3, Biomedicines. 2023 Aug 17;11(8):2287. doi: 10.3390/biomedicines11082287
https://pmc.ncbi.nlm.nih.gov/articles/PMC10452662

The Ethical Significance of PostVaccination COVID19 Transmission Dynamics,
Steven R. Kraaijeveld, J Bioeth Inq. 2022 Dec 21;20(1):21–29. doi: 10.1007/s11673-022-10223-6
https://pmc.ncbi.nlm.nih.gov/articles/PMC9768787

SARS-CoV-2 Spike Protein Accumulation in the Skull-Meninges- Brain Axis: Potential Implications for Long-Term Neurological Complications in post-COVID-19,
Zhouyi Rong1,2,15†, Hongcheng Mai1,2,15†, Saketh Kapoor1†, Victor G. Puelles3,4,13,14, Jan Czogalla3,4, Julia Schädler5, Jessica Vering5, Claire Delbridge6, Hanno Steinke7, Hannah Frenzel7, Katja Schmidt7, Özüm Sehnaz Caliskan9, Jochen Martin Wettengel10, Fatma Cherif11, Mayar Ali1,16, Zeynep Ilgin Kolabas1,2,16, Selin Ulukaya1, Izabela Horvath1,17, Shan Zhao1, Natalie Krahmer9, Sabina Tahirovic11, Ali Önder Yildirim12,Tobias B. Huber3,4, Benjamin Ondruschka3,5, Ingo Bechmann7, Gregor Ebert8, Ulrike Protzer10, Harsharan Singh Bhatia1,2, Farida Hellal1,2, Ali Ertürk1,2* , Cell Host Microbe, 2024 Dec 11;32(12):2112-2130.e10. doi: 10.1016/j.chom.2024.11.007. Epub 2024 Nov 29. 
https://pubmed.ncbi.nlm.nih.gov/39615487/

Subscribe To Our Bi-weekly Newsletter

Welcome to our new website, We have new content being added all the time, Sign up to receive regular updates.